z-logo
open-access-imgOpen Access
Lymphatic Filariasis Model with Prevention and Treatment in Human Under Treatment Barriers
Author(s) -
Aziza Juma Iddi
Publication year - 2020
Publication title -
international journal of scientific research in science, engineering and technology
Language(s) - English
Resource type - Journals
eISSN - 2395-1990
pISSN - 2394-4099
DOI - 10.32628/ijsrset207263
Subject(s) - lymphatic filariasis , disease , persistence (discontinuity) , extinction (optical mineralogy) , basic reproduction number , population , medicine , intervention (counseling) , transmission (telecommunications) , intensive care medicine , immunology , environmental health , filariasis , biology , computer science , paleontology , telecommunications , geotechnical engineering , helminths , engineering , psychiatry
In this paper, a deterministic Lymphatic Filariasis (LF) model with preventive measures in human and treatment barriers is developed and analysed to assess the impact of treatment barriers on the transmission dynamics of LF in endemic areas. Qualitative analysis and numerical simulation are presented in terms of the reproduction number of the model in the absence and presence of treatment barriers. It is established that the treatment intervention has shown improvement in the reduction of LF infection in the population. Furthermore, in the absence of treatment barriers the model guaranteed disease extinction behaviour, while in the presence of treatment barriers the model shows disease persistence behaviour when . This means that in the presence of treatment barriers there is coexistence of the stable disease-free state and the stable persistent state of the disease when . The persistence behaviour may be due to plentiful infected individuals who accumulate in the community due to treatment barriers while the disease has no natural recovery. The numerical simulations are performed to complement the analytical results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here